Veronica Torras-Vives
Overview
Explore the profile of Veronica Torras-Vives including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ochoa-Gondar O, Torras-Vives V, de Diego-Cabanes C, Satue-Gracia E, Vila-Rovira A, Forcadell-Perisa M, et al.
BMC Pulm Med
. 2023 Jun;
23(1):200.
PMID: 37291502
Background: Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of...
2.
Ochoa-Gondar O, Torras-Vives V, de Diego-Cabanes C, Satue Gracia E, Forcadell-Peris M, Vila-Corcoles A
Aten Primaria
. 2023 Apr;
55(7):102631.
PMID: 37119778
Objective: To analyse population-based incidence and lethality of pneumococcal pneumonia (PP) requiring hospitalisation among Catalonian adults after universal vaccination implementation in infants. Design: Population-based cohort study. Setting: Primary care/hospital, Catalonia....
3.
Vila-Corcoles A, Ochoa-Gondar O, de Diego-Cabanes C, Satue-Gracia E, Torras-Vives V, Forcadell-Peris M, et al.
Vaccine X
. 2023 Feb;
13:100264.
PMID: 36798107
Background: At present, because of indirect effects derived from routine childhood immunisation, clinical benefits vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPsV23) and/or the 13-valent pneumococcal conjugate vaccine (PCV13)...